Press release
Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by Aging Population, Degenerative Disorders, and Technological Innovation | DelveInsight
Global Spinal Implants Market
Spinal implants play a pivotal role in stabilizing the spine, correcting deformities, and promoting spinal fusion after trauma or disease. The market comprises fusion implants (pedicle screws, rods, cages), non-fusion devices (artificial discs, dynamic stabilization systems), and minimally invasive systems. Technological advancements in 3D-printed, bioresorbable, and titanium-coated implants are enhancing integration, reducing complications, and improving patient mobility post-surgery.
DelveInsight's Spinal Implants Market Insights, Competitive Landscape, and Market Forecast - 2032 provides an in-depth analysis of market dynamics across key geographies, including the US, EU4 (Germany, France, Italy, Spain), the UK, Japan, and others. The report explores the market by device type, indication (trauma, degenerative disc disease, scoliosis, etc.), approach (anterior, posterior, lateral), and healthcare setting.
Top players such as Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., and Orthofix Medical Inc., are investing in robotics integration, image-guided navigation, and patient-specific implant technologies. These innovations are redefining spine surgery with improved precision, faster recovery times, and better long-term outcomes.
As global awareness around spinal health grows and surgical tools continue to evolve, the spinal implants market is poised for robust growth, focusing on patient safety, long-term performance, and customized care delivery.
Explore the latest trends and growth drivers in the spinal implants market-download your sample report now https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the Spinal Implants Market Report
• The global spinal implants market was valued at USD 14.32 billion in 2024 and is projected to grow at a 5.5% CAGR, reaching USD 21.9 billion by 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global spinal implants market during the forecast period.
• Notable spinal implants companies such as Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc., Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc., and several others are currently operating in the spinal implants market.
• In May 2025, Neuralink announced that it has received the FDA's "breakthrough" designation for its device aimed at restoring communication for individuals with severe speech impairment. The device, designed to assist patients with conditions like amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, cerebral palsy, and multiple sclerosis, represents a significant step forward in neurotechnology.
• In January 2025, Life Spine, Inc., a medical device company specializing in spinal disorder treatments, announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market its ProLift Pivot Expandable Spacer System.
• In January 2025, Stryker, a global leader in medical technologies, announced a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers, LLC, a family-owned investment firm specializing in the neuro-musculoskeletal space, to create a newly formed company called VB Spine, LLC.
• In January 2024, Providence Medical Technology, Inc. received FDA clearance for its CAVUX® FFS-LX: Lumbar Facet Fixation System, designed for use in lumbar spinal fusion surgery.
To read more about the latest highlights related to the spinal implants market, get a snapshot of the key highlights entailed in the global spinal implants market report here https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Spinal Implants Overview
Spinal implants are medical devices used to treat various spinal conditions, including degenerative disc disease, spinal fractures, scoliosis, and spondylolisthesis. These implants help stabilize the spine, promote fusion between vertebrae, or preserve motion, depending on the type and purpose of the device. Common types of spinal implants include rods, screws, plates, interbody cages, and artificial discs. Made from materials like titanium, stainless steel, and PEEK, they offer durability and biocompatibility. Advances in minimally invasive surgery, 3D printing, and biologically active coatings have enhanced implant precision and patient outcomes. As spinal disorders rise globally, especially among aging populations, the demand for effective and long-lasting spinal implants continues to grow.
Spinal Implants Market Insights
North America is projected to lead the spinal implants market in 2024, driven by the high prevalence of spinal disorders, advanced healthcare infrastructure, and strong presence of key players. The region benefits from the rapid adoption of innovative technologies, favorable reimbursement policies, and a growing volume of spinal surgeries.
According to the American Association of Neurological Surgeons (2024), about 450,000 people in the U.S. are living with spinal cord injuries (SCIs), with around 17,000 new cases each year. Additionally, a 2022 NIH study reported approximately 1.6 million spinal surgeries in North America, highlighting the rising demand for spinal implants due to trauma-related spinal injuries.
Product innovations also support market growth. For example, in September 2023, ZimVie Inc. received FDA approval to begin a U.S. trial for its Mobi-C® Cervical Disc Hybrid system, further strengthening its market position.
These factors collectively position North America as the dominant region in the spinal implants market.
To know more about why North America is leading the market growth in the spinal implants market, get a snapshot of the spinal implants market outlook here https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Spinal Implants Market Dynamics
According to the World Health Organization (2024), over 15 million people worldwide live with spinal cord injuries (SCIs), often caused by road accidents, falls, or sports injuries. These cases typically require surgical intervention, where spinal implants play a vital role in stabilizing the spine and aiding recovery. The rising incidence of such injuries, combined with the growing demand for minimally invasive solutions, is driving market growth.
Low back pain is another major contributor to the spinal implant market. WHO (2023) reported that 619 million people globally were affected by low back pain in 2020, a number expected to reach 843 million by 2050. Structural issues and nerve compression often necessitate surgical intervention, further increasing the demand for spinal implants.
Additionally, increased R&D and innovation are propelling the market forward. Companies are developing next-gen implants using technologies like 3D printing, AI, and bioactive coatings. For instance, in December 2024, Carlsmed received FDA 510(k) clearance for its AI-enabled aprevo® Cervical ACDF Interbody System, highlighting the shift toward personalized spine surgery.
Despite this progress, the market faces challenges such as surgical complications, revision risks, and stringent regulatory pathways, which can delay approvals and add to development costs. However, the overall outlook for the spinal implant market remains positive through 2032.
Get a sneak peek at the spinal implants market dynamics @ https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
Spinal Implants Market CAGR: ~5.50%
Key Spinal Implants Companies: Zimmer Biomet, Medtronic plc., Johnson & Johnson Services, Inc., Stryker Corporation, B. Braun Melsungen AG, NuVasive®, Inc., Orthofix Medical Inc., XTANT MEDICAL, RTI Surgical, Life Spine, Inc., Globus Medical, Captiva Spine, Inc., Medacta International, ATEC Spine, Inc., Advin Health Care, Auxein Medical, Aurora Spine, Spineology Inc., Camber Spine Technologies, LLC, Exactech, Inc.,, and others.
Spinal Implants Market Segmentation
Market Segmentation By Product Type: Spinal Fusion & Fixation Devices [Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices], Motion Preservation/Non-Fusion Devices [Artificial Disc Replacement, Dynamic Stabilization Devices, Annulus Repair Devices, and Others], Vertebral Compression Fracture Treatment Devices/Spine Augmentation Devices [Vertebroplaty Devices, Balloon Kyphoplasty Devices], Spine Biologics [Demineralized Bone Matrix, Bone Morphogenetic Proteins, Allografts, and Others].
Market Segmentation By End-User: Hospitals, Orthopedic Clinics, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World.
Which MedTech key players in the spinal implants market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/spinal-implants-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. Spinal Implants Market Report Introduction
2. Spinal Implants Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Spinal Implants Market Key Factors Analysis
6. Spinal Implants Market Porter's Five Forces Analysis
7. Spinal Implants Market Layout
8. Spinal Implants Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by Aging Population, Degenerative Disorders, and Technological Innovation | DelveInsight here
News-ID: 4093005 • Views: …
More Releases from DelveInsight
Glaucoma - Pipeline Insight, 2025: Advancing Beyond IOP Control Toward Neuroprot …
Glaucoma, a leading cause of irreversible blindness worldwide, is traditionally managed through therapies that lower intraocular pressure (IOP). However, as understanding of the disease evolves, there is growing recognition of the need for neuroprotective strategies that address underlying optic nerve damage and retinal ganglion cell (RGC) loss.
DelveInsight's "Glaucoma - Pipeline Insight, 2025" analyzes over 50+ emerging therapies that go beyond conventional IOP-lowering agents. The pipeline includes novel mechanisms such as…
Gene Therapy Market to Grow at a CAGR of 19.25% Through 2032, Driven by Breakthr …
The global gene therapy market is on a strong upward trajectory, fueled by scientific advancements, growing approvals, and rising demand for personalized and curative treatments. With a projected CAGR of 19.25% through 2032, gene therapy is transforming the treatment paradigm for genetic disorders, rare diseases, cancers, and even select infectious and neurodegenerative conditions.
Gene therapies offer the potential for long-term or permanent cures by delivering, altering, or replacing faulty genes at…
Myelofibrosis - Pipeline Insight, 2025: Novel Disease-Modifying Therapies Target …
Myelofibrosis, a rare and chronic myeloproliferative neoplasm, is characterized by bone marrow fibrosis, abnormal blood cell production, and splenomegaly. Historically treated with symptom-focused therapies, the treatment landscape for myelofibrosis is now undergoing a significant transformation as disease-modifying approaches gain traction.
DelveInsight's "Myelofibrosis - Pipeline Insight, 2025" highlights over 40+ active pipeline candidates targeting various pathogenic mechanisms, including JAK-STAT signaling, fibrosis pathways, anemia management, and the malignant stem cell clone. Prominent therapeutic…
Thalassemia - Pipeline Insight, 2025: Advancing Curative and Disease-Modifying T …
Thalassemia, a group of inherited blood disorders characterized by defective hemoglobin synthesis, continues to pose significant clinical challenges despite existing transfusion and iron chelation therapies. As the focus shifts from symptomatic management to curative and disease-modifying strategies, the thalassemia treatment pipeline is undergoing a major transformation.
DelveInsight's "Thalassemia - Pipeline Insight, 2025" highlights over 28+ emerging therapies in development, ranging from gene therapies and gene editing approaches to novel erythroid maturation…
More Releases for Spinal
Spinal Non-Fusion
Spinal implants are devices used for the treatment of spinal disorders such as disproportion and instability of spine. Spine surgical devices are broadly classified into fusion and non-fusion devices. Fusion devices heals by providing immediate and rigid immobilization, and non-fusion devices treats by replacing pro-inflammatory tissues, restoring spinal alignment, and decompressing neural elements while preserving functional movements rather than obliterating it. The advantages such as prolonged recuperation time, bone graft…
Different Approaches to Spinal Fusion Market And Control Spinal Deformity Develo …
Spinal fusion is surgery to permanently join together two or more bones in the spine so there is no movement between them. For patients who require spinal fusion surgery to treat lumbar degenerative disc disease (DDD), spinal fusion device is a treatment option.
Spinal fusion has been used for many years to treat many painful conditions in the lumbar (lower) spine. Over the past decade, there has been dramatic improvement in…
Spinal Cord Compression-Spinal Stenosis Market Progresses for Huge Profits by 20 …
The Global Spinal Cord Compression-Spinal Stenosis Market is expected to reach $ 8.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 11.5 % during 2017-2023.
Spinal stenosis is the abnormal narrowing of spinal canal causing it to restrict, which may result in a neurological deficit due to interference with neurological fibres. The associated symptoms include pain, numbness, loss of motor control etc.…
Spinal Cord Compression-Spinal Stenosis Market Report: Industry Manufacturers An …
Marketresearchfuture.com includes Global Spinal Cord Compression-Spinal Stenosis Market by indications, by diagnosis, by end users - Global Forecast till 2023 is new report.
Spinal cord compression is the second most frequent neurologic complication of cancer. Only in the United States, each year nearly 20,000 people with cancer develop spinal cord compression; this affected population represents 5% to 10% of the general cancer population.
Request Sample copy of Spinal cord compression-spinal stenosis…
Spinal Trauma Devices Market: Spinal Trauma Devices Sales to Surge Rapidly in Re …
The global spinal trauma devices market is dynamic and highly competitive. Only a couple of companies account for a substantial share in the market, thus lending it an oligopolistic vendor landscape. The market is largely dominated by DePuy Synthes, Medtronic, NuVasive, Inc., Stryker Corporation, and Globus Medical, Inc. The cumulative share of these companies added up to 79.1% in 2014, says Transparency Market Research (TMR) in a new report.
As…
Spinal Implants and Spinal Devices Market Analysis, Development and Demand Forec …
The global spinal implants and spinal devices market is growing, due to increasing demand for minimally invasive surgeries, increasing number of hospitals and surgical centers, and commercial applications in areas, such as nucleus arthroplasty, stem cell technology and artificial disk replacement. The spinal fusion and fixation technology dominates the market and the non-fusion/ motion preservation technology segment is expected to grow with the fastest rate during the forecast period, due…
